Cats of Tokyo – In a move that could fundamentally change the lifespan of domestic cats, the Tokyo-based startup Institute for AIM Medicine (IAM) formally filed for manufacturing and marketing approval of its flagship drug, FeliAIM, on April 24, 2026....
Cats Could Live to 30: Japanese Startup Seeks Approval for Breakthrough Kidney Treatment
